$0
$103,000
0.0% of portfolio
1
Q4 2024
New
$0
$137 Million
0.0% of portfolio
2,350
Q4 2022
Reduced 24.19%
$0
$39.3 Million
0.0% of portfolio
567
Q4 2022
New
$0
$262 Million
0.0% of portfolio
22,836
Q1 2025
Reduced 7.71%
$0
$203 Million
0.0% of portfolio
5,683
Q1 2025
New
$0
$13.7 Million
0.0% of portfolio
202
Q1 2024
Added 27.85%
$0
$21.1 Million
0.0% of portfolio
150
Q4 2024
Added 50.0%
$0
$111,000
0.0% of portfolio
1
Q2 2024
New
$0
$4.09 Million
0.0% of portfolio
40
Q4 2024
Reduced 94.04%
$0
$160 Million
0.0% of portfolio
2,232
Q2 2024
Reduced 9.16%
$12.9B
$918,000
0.0% of portfolio
7
Q1 2025
Reduced 99.92%
$0
$272 Million
0.0% of portfolio
3,769
Q1 2025
Added 8.52%
$52.2B
$86.4 Million
0.0% of portfolio
2,091
Q1 2025
Reduced 0.05%
$12.8B
$11.2 Million
0.0% of portfolio
209
Q1 2025
Reduced 99.41%
$1.17B
$74,000
0.0% of portfolio
4
Q3 2024
New
$466M
$4.5 Million
0.0% of portfolio
2,074
Q1 2025
New
$13B
$3.61 Million
0.0% of portfolio
100
Q3 2022
Reduced 44.13%
Karyopharm Therapeutics Inc
-
$11.3 Million
0.0% of portfolio
-
Q1 2025
New
$32.1B
$114 Million
0.0% of portfolio
2,085
Q4 2024
Reduced 2.39%
$4.64B
$180 Million
0.0% of portfolio
3,086
Q1 2025
Reduced 0.32%
$27.1B
$198 Million
0.0% of portfolio
2,403
Q1 2025
Reduced 67.7%
-
$192 Million
0.0% of portfolio
-
Q1 2025
Added 1,192.44%
$47.2B
$35 Million
0.0% of portfolio
1,000
Q1 2025
Added 412.82%
$17.1B
$63 Million
0.0% of portfolio
3,995
Q4 2024
Added 208.49%
$29.1B
$11.2 Million
0.0% of portfolio
75
Q1 2025
Reduced 86.96%
$804M
$125 Million
0.0% of portfolio
8,787
Q1 2025
Added 104.97%
$13.4B
$127 Million
0.0% of portfolio
6,022
Q1 2025
Reduced 12.46%
Kiniksa Pharmaceuticals Intl
-
$2.17 Million
0.0% of portfolio
-
Q1 2025
New
$6.94B
$203,000
0.0% of portfolio
2
Q4 2024
Added 100.0%
$22.7M
$256,000
0.0% of portfolio
200
Q1 2025
Added 100.0%
$1.22B
$4.13 Million
0.0% of portfolio
500
Q4 2024
New
$0
$528,000
0.0% of portfolio
60
Q2 2024
New
$21.7B
$5.55 Million
0.0% of portfolio
220
Q1 2025
Reduced 96.78%
$198M
$99,000
0.0% of portfolio
100
Q2 2024
New
$33.7B
$132 Million
0.0% of portfolio
4,453
Q1 2025
Reduced 4.56%
$0
$555 Million
0.0% of portfolio
15,841
Q1 2025
Reduced 25.53%
$0
$45.7 Million
0.0% of portfolio
2,450
Q4 2021
New
$0
$11.4 Million
0.0% of portfolio
400
Q2 2024
Reduced 37.21%
$2.07B
$52.6 Million
0.0% of portfolio
1,570
Q3 2024
Added 11.58%
$8.86B
$45.8 Million
0.0% of portfolio
1,425
Q1 2025
Reduced 1.59%
$50.3B
$274 Million
0.0% of portfolio
1,308
Q1 2025
Added 300.0%
-
$138 Million
0.0% of portfolio
-
Q1 2025
Reduced 37.58%
$1.38B
$85.5 Million
0.0% of portfolio
7,500
Q4 2024
New
$115M
$3.65 Million
0.0% of portfolio
1,500
Q4 2022
Added 29,900.0%
-
$241,000
0.0% of portfolio
-
Q2 2023
New
$102M
$897,000
0.0% of portfolio
573
Q1 2025
Reduced 46.6%
$36.9B
$456 Million
0.0% of portfolio
11,645
Q1 2025
Added 5.17%
$19.9B
$611 Million
0.0% of portfolio
9,004
Q1 2025
Added 62.41%
-
$84.2 Million
0.0% of portfolio
-
Q1 2025
Reduced 5.18%
$2.47B
$4.72 Million
0.0% of portfolio
54
Q3 2024
Added 68.75%